Pharmacologic and genetic manipulation of MMP-2 and -9 affects retinal neovascularization in rodent models of OIR.
about
Endothelial tip cells in ocular angiogenesis: potential target for anti-angiogenesis therapyCross-talk between vascular endothelial growth factor and matrix metalloproteinases in the induction of neovascularization in vivoThe role of PGE2 receptor EP4 in pathologic ocular angiogenesis.Macrophage metalloelastase (MMP-12) deficiency mitigates retinal inflammation and pathological angiogenesis in ischemic retinopathy.Adult vascular wall resident multipotent vascular stem cells, matrix metalloproteinases, and arterial aneurysms.CCN1/Cyr61-PI3K/AKT signaling promotes retinal neovascularization in oxygen-induced retinopathyConnective tissue growth factor regulates retinal neovascularization through p53 protein-dependent transactivation of the matrix metalloproteinase (MMP)-2 geneMolecular imaging of retinal disease.Whole brain radiation-induced cognitive impairment: pathophysiological mechanisms and therapeutic targetsVEGF secreted by hypoxic Müller cells induces MMP-2 expression and activity in endothelial cells to promote retinal neovascularization in proliferative diabetic retinopathy.In Vivo Angiogenic Capacity of Stem Cells from Human Exfoliated Deciduous Teeth with Human Umbilical Vein Endothelial Cells.Novel targets against retinal angiogenesis in diabetic retinopathy.Enzymatic vitrectomy for diabetic retinopathy and diabetic macular edema.The effects of nepafenac and amfenac on retinal angiogenesis.Expression and function of Delta-like ligand 4 in a rat model of retinopathy of prematurityEfficacy of intravitreal captopril on oxygen-induced retinopathy in mice.IGF-1R Regulates the Extracellular Level of Active MMP-2, Pathological Neovascularization, and Functionality in Retinas of OIR Mouse Model.Retinal and choroidal angiogenesis: a review of new targets.Cell Based Therapeutic Approach in Vascular Surgery: Application and Review.
P2860
Q26865091-95B968C6-EB41-45B7-8438-644CCED88D7FQ28576485-0CC602B0-8433-4364-B49E-EC378EE85D83Q33459697-0EA5B698-BF5E-4C82-BAD2-6C1DDF4E4A90Q34534458-F187C2AE-03D1-4E13-A008-865D35FA7356Q35239944-6BB999D4-1BFF-4DEB-86EA-8029AAD3E36AQ36369272-BFC967A2-33CA-4DB4-9336-61B51183DE1CQ36418892-D3217E42-9C66-413B-924E-FC9715BB3CEDQ36696874-55662825-402A-40D6-8065-39321F7CBE88Q37145380-2F745162-93DF-4127-8B89-C9C2B0F3AA99Q37251091-E9B761F2-CA72-4F50-A69A-DBB9C9026E16Q37446733-747404A8-A8BC-4A15-8645-07635332DF57Q38013679-D3C53587-BBC9-4D9F-A7F2-A5AA653B556FQ38174893-8CE42BD9-614C-4A22-B4A0-1FDA2B1C3AEFQ41810246-28A7359D-2596-4888-B354-62622AE5A3E5Q41942352-1CB9E342-6FA2-4B85-8629-DA834FE2D89FQ42142435-159BC728-FE7C-443D-85F3-B8425B4E1AADQ50948454-158F6165-D1AA-443E-A18A-4901FF85D5D7Q53098522-7291A714-43E4-4DC8-B47F-DE590A1B0BE8Q55346184-18E44FA3-DAAC-460B-9053-23C5A4D88143
P2860
Pharmacologic and genetic manipulation of MMP-2 and -9 affects retinal neovascularization in rodent models of OIR.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Pharmacologic and genetic mani ...... ation in rodent models of OIR.
@en
type
label
Pharmacologic and genetic mani ...... ation in rodent models of OIR.
@en
prefLabel
Pharmacologic and genetic mani ...... ation in rodent models of OIR.
@en
P2093
P2860
P356
P1476
Pharmacologic and genetic mani ...... zation in rodent models of OIR
@en
P2093
David P Bingaman
Gary W McCollum
Jesse D Kay
Jessica A Fowler
John S Penn
Joshua M Barnett
Rui-Qin Liu
P2860
P304
P356
10.1167/IOVS.06-0082
P407
P577
2007-02-01T00:00:00Z